HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis.

AbstractBACKGROUND & AIMS:
Hereditary hemochromatosis (HH) is the most common form of genetic iron loading disease. It is mainly related to the homozygous C282Y/C282Y mutation in the HFE gene that is, however, a necessary but not a sufficient condition to develop clinical and even biochemical HH. This suggests that modifier genes are likely involved in the expressivity of the disease. Our aim was to identify such modifier genes.
METHODS:
We performed a genome-wide association study (GWAS) using DNA collected from 474 unrelated C282Y homozygotes. Associations were examined for both quantitative iron burden indices and clinical outcomes with 534,213 single nucleotide polymorphisms (SNP) genotypes, with replication analyses in an independent sample of 748 C282Y homozygotes from four different European centres.
RESULTS:
One SNP met genome-wide statistical significance for association with transferrin concentration (rs3811647, GWAS p value of 7×10(-9) and replication p value of 5×10(-13)). This SNP, located within intron 11 of the TF gene, had a pleiotropic effect on serum iron (GWAS p value of 4.9×10(-6) and replication p value of 3.2×10(-6)). Both serum transferrin and iron levels were associated with serum ferritin levels, amount of iron removed and global clinical stage (p<0.01). Serum iron levels were also associated with fibrosis stage (p<0.0001).
CONCLUSIONS:
This GWAS, the largest one performed so far in unselected HFE-associated HH (HFE-HH) patients, identified the rs3811647 polymorphism in the TF gene as the only SNP significantly associated with iron metabolism through serum transferrin and iron levels. Because these two outcomes were clearly associated with the biochemical and clinical expression of the disease, an indirect link between the rs3811647 polymorphism and the phenotypic presentation of HFE-HH is likely.
AuthorsMarie de Tayrac, Marie-Paule Roth, Anne-Marie Jouanolle, Hélène Coppin, Gérald le Gac, Alberto Piperno, Claude Férec, Sara Pelucchi, Virginie Scotet, Edouard Bardou-Jacquet, Martine Ropert, Régis Bouvet, Emmanuelle Génin, Jean Mosser, Yves Deugnier
JournalJournal of hepatology (J Hepatol) Vol. 62 Issue 3 Pg. 664-72 (Mar 2015) ISSN: 1600-0641 [Electronic] Netherlands
PMID25457201 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Chemical References
  • HFE protein, human
  • Hemochromatosis Protein
  • Histocompatibility Antigens Class I
  • Membrane Proteins
  • Transferrin
  • Iron
Topics
  • Adult
  • Amino Acid Substitution
  • Female
  • France
  • Genes, Modifier
  • Genome-Wide Association Study
  • Hemochromatosis (genetics, metabolism)
  • Hemochromatosis Protein
  • Histocompatibility Antigens Class I (genetics)
  • Homozygote
  • Humans
  • Iron (blood, metabolism)
  • Italy
  • Male
  • Membrane Proteins (genetics)
  • Middle Aged
  • Models, Biological
  • Polymorphism, Single Nucleotide
  • Transferrin (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: